Effector Therapeutics Inc.
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$0.29avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Effector Therapeutics Inc. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($20K) and Blackstone Inc. ($15K).
- Company
- Effector Therapeutics Inc.
- CUSIP
- 28202V108
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Parallel Advisors, LLC | 0.00% | No change | 67,738 | $20K |
| Blackstone Inc. | 0.00% | No change | 52,343 | $15K |
"% of holder's portfolio" is EFFECTOR THERAPEUTICS INC's weight in each manager's 13F, not the share of Effector Therapeutics Inc. the manager owns.